Tetsuya Nishida

3.8k total citations
146 papers, 2.4k citations indexed

About

Tetsuya Nishida is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Tetsuya Nishida has authored 146 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 43 papers in Hematology and 27 papers in Oncology. Recurrent topics in Tetsuya Nishida's work include Hematopoietic Stem Cell Transplantation (40 papers), Immune Cell Function and Interaction (33 papers) and T-cell and B-cell Immunology (20 papers). Tetsuya Nishida is often cited by papers focused on Hematopoietic Stem Cell Transplantation (40 papers), Immune Cell Function and Interaction (33 papers) and T-cell and B-cell Immunology (20 papers). Tetsuya Nishida collaborates with scholars based in Japan, United States and United Kingdom. Tetsuya Nishida's co-authors include Makoto Murata, Seitaro Terakura, Hitoshi Kiyoi, Tomoki Naoe, Stanley R. Riddell, Tatsunori Goto, Marie Bleakley, Ryo Hanajiri, Keisuke Watanabe and Michael Hudecek and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Applied Physics Letters.

In The Last Decade

Tetsuya Nishida

129 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuya Nishida Japan 24 772 765 519 502 356 146 2.4k
Masayoshi Ono Japan 20 599 0.8× 567 0.7× 594 1.1× 363 0.7× 452 1.3× 109 2.6k
Masaki Hara Japan 37 1.1k 1.4× 617 0.8× 781 1.5× 159 0.3× 337 0.9× 224 5.2k
Nobuhiro Kimura Japan 23 922 1.2× 711 0.9× 386 0.7× 283 0.6× 196 0.6× 136 2.3k
Tomoyuki Endo Japan 26 691 0.9× 548 0.7× 641 1.2× 519 1.0× 85 0.2× 147 2.6k
Atsushi Horiuchi Japan 25 430 0.6× 426 0.6× 648 1.2× 174 0.3× 115 0.3× 188 2.8k
Hideo Tanaka Japan 24 736 1.0× 1.0k 1.4× 1.3k 2.4× 1.3k 2.5× 199 0.6× 104 3.2k
Joseph J. Drabick United States 29 830 1.1× 1.3k 1.7× 1.0k 2.0× 140 0.3× 235 0.7× 154 4.1k
Noriyuki Saito Japan 19 339 0.4× 418 0.5× 480 0.9× 501 1.0× 58 0.2× 71 1.8k
Keisuke Kato Japan 28 181 0.2× 517 0.7× 563 1.1× 208 0.4× 149 0.4× 138 3.0k
Tauseef Ahmed United States 32 231 0.3× 862 1.1× 1.1k 2.2× 525 1.0× 113 0.3× 170 4.8k

Countries citing papers authored by Tetsuya Nishida

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Nishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Nishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Nishida more than expected).

Fields of papers citing papers by Tetsuya Nishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Nishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Nishida. The network helps show where Tetsuya Nishida may publish in the future.

Co-authorship network of co-authors of Tetsuya Nishida

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Nishida. A scholar is included among the top collaborators of Tetsuya Nishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Nishida. Tetsuya Nishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harada, Naonori, Junya Kanda, Hiromi Hayashi, et al.. (2025). Evaluation of the Prognostic Impact of Infused CD34 Positive Cell Dose in Haplo-Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide Using a Restricted Cubic Spline Curve. Transplantation and Cellular Therapy. 31(2). S262–S262. 1 indexed citations
2.
Arai, Yasuyuki, Tadakazu Kondo, Shigeki Hirabayashi, et al.. (2025). HLA‐matched related peripheral blood stem cell and bone marrow transplantation with RIC regimens yield comparable outcomes for adult AML. eJHaem. 6(1). e21088–e21088.
3.
Terakura, Seitaro, Yuki Takeuchi, Takahiko Sato, et al.. (2025). Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study. Cytotherapy. 27(8). 962–972.
6.
Kuwatsuka, Yachiyo, Rika Kasajima, Rui Yamaguchi, et al.. (2024). Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation. Transplantation and Cellular Therapy. 30(4). 444.e1–444.e11. 1 indexed citations
7.
Tamaki, Masaharu, Yu Akahoshi, Yoshihiro Inamoto, et al.. (2024). Associations between acute and chronic graft-versus-host disease. Blood Advances. 8(16). 4250–4261.
8.
Jo, Tomoyasu, Yu Akahoshi, Tadakazu Kondo, et al.. (2024). First complete remission favours haploidentical haematopoietic stem cell transplantation with post‐transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 204(5). 1913–1919. 2 indexed citations
9.
Fuji, Shigeo, Ayumu Ito, Noriko Doki, et al.. (2024). Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation. Transplantation and Cellular Therapy. 30(5). 514.e1–514.e13.
10.
Ito, Yuri, Yoshihiro Inamoto, Koichi Miyamura, et al.. (2023). Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades. Transplantation and Cellular Therapy. 29(12). 768.e1–768.e10. 3 indexed citations
11.
12.
Koh, Hideo, Takaaki Konuma, Yoshimitsu Shimomura, et al.. (2023). HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome. Transplantation and Cellular Therapy. 30(3). 316.e1–316.e12. 1 indexed citations
13.
Kaito, Satoshi, Y. Nakajima, Konan Hara, et al.. (2020). Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation. Blood Advances. 4(6). 1051–1061. 19 indexed citations
14.
Miyao, Kotaro, Seitaro Terakura, Shingo Okuno, et al.. (2018). Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs. Cancer Immunology Research. 6(6). 733–744. 16 indexed citations
15.
Nishida, Tetsuya, et al.. (2018). Power Generation System of Exhaust Heat from Marine Engine Using HFC-245fa as a Working Fluid. Doryoku, Enerugi Gijutsu Shinpojiumu koen ronbunshu/Doryoku, enerugi gijutsu no saizensen koen ronbunshu. 2018.23(0). E113–E113. 1 indexed citations
16.
Sakemura, Reona, Seitaro Terakura, Keisuke Watanabe, et al.. (2016). A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration. Cancer Immunology Research. 4(8). 658–668. 129 indexed citations
17.
Nishida, Tetsuya, et al.. (2016). Comparison of Displacement Measurements in Exposed Type Column Base Using Piezoelectric Dynamic Sensors and Static Sensors. National Remote Sensing Bulletin. 4(5). 23. 1 indexed citations
18.
Nishida, Tetsuya, et al.. (2011). D117 Performance Analysis of Power System Utilizing Waste Heat Energy. Doryoku, Enerugi Gijutsu Shinpojiumu koen ronbunshu/Doryoku, enerugi gijutsu no saizensen koen ronbunshu. 2011.16(0). 81–82. 1 indexed citations
19.
Bleakley, Marie, Brith Otterud, Michael Hudecek, et al.. (2010). Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells. Blood. 115(23). 4923–4933. 79 indexed citations
20.
Nishida, Tetsuya, Michael Hudecek, Ana Kostić, et al.. (2009). Development of Tumor-Reactive T Cells After Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for Chronic Lymphocytic Leukemia. Clinical Cancer Research. 15(14). 4759–4768. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026